Skip to main content
ILYANG PHARMACEUTICAL CO.,LTD logo

ILYANG PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 007570 ISIN · KR7007570005 KO Manufacturing
Open in API
Filings indexed 225 across all filing types
Latest filing 2021-10-13 Major Shareholding Noti…
Country KR South Korea
Listing KO 007570

About ILYANG PHARMACEUTICAL CO.,LTD

https://www.ilyang.co.kr

Ilyang Pharmaceutical, established in 1946, is a research-oriented company that develops and manufactures a diverse portfolio of pharmaceutical products. The company focuses on developing new chemical entities (NCEs) and produces a range of medicines targeting digestive, respiratory, and circulatory system disorders, as well as neoplasms and infectious diseases. Key developments include 'Ilaprazole' (Noltec), a proton pump inhibitor for acid-related disorders, and 'Supect' (Radotinib), a treatment for chronic myeloid leukemia. Its product line also encompasses general drugs, antibiotics, anti-inflammatory agents, nutritional supplements, and well-established consumer health brands like the digestive aid 'NORUMO' and the nutritional drink 'Wonbi-D'.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Il-Yang Pharmaceutical. It details specific share transactions (purchases) made by a major shareholder/director (Jung Yoo-seok). This type of filing, which reports changes in ownership by insiders or major shareholders, is classified as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-10-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details specific share transactions (purchases) made by an executive (Jung Yu-seok) of ILYANG PHARMACEUTICAL CO., LTD. This type of filing is a standard disclosure for insider trading/director dealings, which corresponds to the 'Director's Dealing' category.
2021-10-06 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a '최대주주등소유주식변동신고서' (Report on Changes in Shareholding by Major Shareholders and Related Parties) for Il-Yang Pharmaceutical. It details specific share purchase transactions by a director/related party (Jung Yoo-seok) and updates the total shareholding status of the major shareholders. This falls under the category of 'Director's Dealing' (DIRS) as it reports insider/major shareholder transactions.
2021-10-06 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service regarding their stake in Il-Yang Pharmaceutical Co., Ltd. This type of filing is a regulatory requirement in South Korea when an entity's shareholding crosses specific thresholds (typically 5%). It is a formal disclosure of ownership changes and does not fit into categories like Annual Reports, Earnings Releases, or Proxy Statements. As it is a specific regulatory disclosure regarding major shareholding, it falls under the 'Major Shareholding Notification' category.
2021-10-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (acquisitions) made by an executive (Jung Yu-seok) of ILYANG PHARMACEUTICAL CO., LTD. This type of filing is a standard regulatory requirement for insiders to disclose their personal trading activities in the company's stock, which corresponds to the 'Director's Dealing' category.
2021-09-28 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Il-Yang Pharmaceutical. It details specific share transactions (purchases) by a major shareholder/insider (Jung Yoo-seok). This falls under the category of 'Major Shareholding Notification' as it tracks changes in significant ownership levels and insider holdings.
2021-09-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.